Trial
NCT03032042
Intestinal Microbiome Post-Azythromycin/Albendazole Treatment
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Francisco
Collaborators
—
Condition
Helminth Infection
Intervention
Azithromycin
Why stopped
We were not able to secure IRB approval in the timeline necessary to do this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-28